Posted on June 6, 2018June 8, 2018 by Pulse AssentISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis Link: ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis Source: BSI Standards Related Posts:New laws to introduce digital labelling for…Government backs SMEs with new Help to Grow campaign…UK government sets out AI Safety Summit ambitionsExpert regional innovation hubs given £75 million…SME Council membership revealed ahead of first meeting
